Pretreatment With Sumatriptan on Cilostazol Induced Headache in Healthy Volunteers
Status:
Completed
Trial end date:
2017-10-18
Target enrollment:
Participant gender:
Summary
To develop a pragmatic migraine model the investigators will induce headache in healthy
volunteers with a phosphodiesterase inhibitor (cilostazol). The participants will be
pre-treated with sumatriptan. If the headache responds to sumatriptan, the model can be used
to test new drug candidates.